MedPath

Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20

Phase 2
Completed
Conditions
Opioid-Related Disorders
Registration Number
NCT00000238
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Brief Summary

The purpose of this study is to assess the degree in which opioid-dependent outpatients discount the value of an additional maintenance dose of buprenorphine under differing states of opioid deprivation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Drug use
Money choice
Heroin craving
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Treatment Research Center

🇺🇸

Burlington, Vermont, United States

© Copyright 2025. All Rights Reserved by MedPath